newsfilter
← Latest News
GlobeNewswire·

Diffusion Pharmaceuticals Announces Closing of $30 Million Bought Deal Offering of Common Stock

CHARLOTTESVILLE, Va., Feb. 17, 2021 (GLOBE NEWSWIRE) -- Diffusion Pharmaceuticals Inc. (NASDAQ: DFFN) (“Diffusion” or the “Company”), an innovative biopharmaceutical company developing novel...